Disruptions to osteo-chondroprogenitor cell differentiation due to activated ERK/SOX9 signaling contributes to the abnormal skeletal development in osteogenesis imperfecta type V. This evidence concerns the gene MAPK1 and osteogenesis imperfecta type 5.